Wegovy in Australia 2026: Availability, Cost and How to Get It
Key Takeaways
Wegovy (semaglutide 2.4mg) is now TGA-registered for weight management in Australia. Here's what you actually need to know about availability, cost and access in 2026.
Wegovy Is Now Available in Australia — Here's What You Actually Need to Know
Wegovy (semaglutide 2.4mg) was officially registered by the Australian Therapeutic Goods Administration (TGA) in early 2025 as a prescription treatment for chronic weight management in adults. This was a significant milestone — it marked the arrival of the first medication specifically approved in Australia for weight loss in adults since liraglutide (Saxenda) received its TGA indication years earlier.
Despite that milestone, most Australians asking about Wegovy are still getting vague or inaccurate information. This post answers the questions that actually matter: whether it's available right now, what it costs, how it differs from Ozempic, and how to access it.
Wegovy vs Ozempic: Same Drug, Very Different Situation
Wegovy and Ozempic both contain the same active ingredient: semaglutide. They are made by the same company (Novo Nordisk). But there are important differences that matter for Australian patients:
- TGA indication: Wegovy is specifically registered for chronic weight management. Ozempic is registered for type 2 diabetes.
- Dose: Wegovy reaches a maintenance dose of 2.4mg per week. Ozempic's maximum is 2mg per week.
- PBS status: Neither is PBS-subsidised for weight loss. Both require private prescriptions for this purpose.
- Clinical significance: The higher dose of Wegovy produces modestly greater weight loss on average compared to lower Ozempic doses, based on trial data.
Is Wegovy Actually Available in Australian Pharmacies?
Yes. As of 2026, Wegovy is available through most Australian pharmacies that stock specialty medications. Supply has stabilised since initial availability, and while stock occasionally varies between individual pharmacies, it is generally accessible with a valid prescription.
It is worth calling ahead to your pharmacy to confirm stock before presenting with a prescription.
What Does Wegovy Cost in Australia?
Wegovy is a private prescription medication for weight management — it is not currently on the PBS for this indication. Typical costs in 2026:
- GP consultation: Can be bulk billed at eligible telehealth services — $0 out of pocket for the appointment
- Wegovy pen (monthly supply, titration doses): Approximately $160–$220 per month at pharmacy
- Wegovy pen (maintenance dose 2.4mg): Approximately $200–$250 per month at pharmacy
Prices vary between pharmacies. It is worth shopping around or asking your GP if they can recommend a compounding-free pharmacy option.
Who Can Prescribe Wegovy in Australia?
Any Australian registered GP can prescribe Wegovy as a private prescription for eligible patients. You do not need a referral to a specialist. You do not need to see an endocrinologist or bariatric physician first.
Thinking about Wegovy?
Our GPs can assess your suitability for semaglutide 2.4mg via bulk billed telehealth consultation.
Telehealth GP consultations — including bulk billed services — are a valid and accessible pathway to Wegovy in Australia.
Who Is Eligible for Wegovy?
The TGA-registered indication for Wegovy is for use in adults with:
- A BMI of 30 kg/m² or greater (obesity), or
- A BMI of 27 kg/m² or greater in the presence of at least one weight-related comorbidity (such as hypertension, type 2 diabetes, dyslipidaemia, or obstructive sleep apnoea)
Your GP will assess your eligibility during the consultation, reviewing your health history, current medications, and any contraindications.
How Does Wegovy Work for Weight Loss?
Semaglutide mimics GLP-1, a hormone naturally released after eating. It works through three primary mechanisms:
- Appetite suppression: Acts on receptors in the brain to reduce hunger signals and food cravings
- Gastric slowing: Slows the rate at which the stomach empties, prolonging feelings of fullness after meals
- Metabolic effects: Improves insulin sensitivity and blood sugar regulation
In the STEP clinical trial program, participants taking semaglutide 2.4mg (Wegovy's dose) alongside lifestyle intervention lost an average of 15–17% of body weight over 68 weeks. This is significantly more than older weight loss medications.
What Are the Side Effects of Wegovy?
The side effect profile is consistent with other GLP-1 medications:
- Very common: Nausea, vomiting, diarrhoea, constipation — most pronounced during dose escalation
- Common: Headache, fatigue, dizziness, injection site reactions
- Rare but serious: Pancreatitis; theoretical thyroid risk in people with relevant personal/family history
Standard practice is to begin at the lowest dose (0.25mg) and escalate slowly over several months to minimise gastrointestinal side effects. Most patients find side effects manageable and improve over time.
How to Access Wegovy Through a Bulk Billed GP
The process is simple:
- Join a waitlist or book directly with a telehealth GP service offering bulk billed weight loss consultations
- Complete a health assessment — this is typically done via a secure online form before your appointment
- Attend a video consultation with an Australian-registered GP
- If appropriate, receive an eScript for Wegovy — sent to your phone or directly to your chosen pharmacy
- Collect your medication and begin your treatment plan
Weight Loss GP Australia offers bulk billed telehealth consultations for eligible patients across QLD, NSW, VIC, WA, SA, ACT, and TAS.
Get a bulk billed Wegovy assessment from home.
Our GPs can assess your suitability for semaglutide 2.4mg via telehealth. Request an appointment — no referral, no waiting room.
Book a Consultation